Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Calcineurin inhibitor blocks tolerance by suppressing donor T cell terminal exhaustion after allogeneic hematopoietic cell transplantation
Hajime Senjo, … , Daigo Hashimoto, Takanori Teshima
Hajime Senjo, … , Daigo Hashimoto, Takanori Teshima
Published October 15, 2024
Citation Information: J Clin Invest. 2024;134(20):e184332. https://doi.org/10.1172/JCI184332.
View: Text | PDF
Letter to the Editor Hematology Article has an altmetric score of 2

Calcineurin inhibitor blocks tolerance by suppressing donor T cell terminal exhaustion after allogeneic hematopoietic cell transplantation

  • Text
  • PDF
Abstract

Authors

Hajime Senjo, Daigo Hashimoto, Takanori Teshima

×

Figure 1

Donor T cell profile on day 14.

Options: View larger image (or click on image) Download as PowerPoint
Donor T cell profile on day 14.
CSP (25 mg/kg) was administered on days ...
CSP (25 mg/kg) was administered on days 0–13 after allo-HCT. (A, B, E, and F) scRNA-seq. (C and D) CD62L on 2C-Tg donor T cells (n = 5/group). Box-and-whisker plot shows the median (vehicle vs. CSP: 2.510 vs. 0.990; line in box), IQR (0.57–3.12 vs. 0.86–2.39; box bounds), and minimum/maximum values (0.43/3.47 vs. 0.61/3.41; whiskers). P > 0.99 by 2-tailed Mann-Whitney U test (D).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 2 X users
1 readers on Mendeley
See more details